Table 3

Clinical information of the patients with KIF11 mutation

Patient no./genderAge at onset/examinationMutationFirst symptomVisual acuityAxial length (mm)Main phenotypesUltrasonographyOFC†Lymphoedema
QT1314I:2/F6 months/23 yearsc.131_132dupATNYS20/250; 20/25018.99; 17.19RFM, TDOD, FRF, RPCNA−4.1
QT1314II:1/F4 months/6 monthsc.131_132dupATNYSLP; NRLONA; NAMC, RFM, TDOD, FRF, RPCMCOD−5.5
QT964II:2/F2 months/5 monthsc.2230C>TCONRLO*15.8; 14.1MC, CORD−5.9
QT964II:3/F2 months/5 monthsc.2230C>TCONRLO*15.5; 14.0MC, CORD−6.4
QT937I:1/MNA/41 yearsc.2863C>TNone20/20; 20/2022.37; 22.37AZNA−0.1
QT937II:1/F3 months/6 monthsc.2863C>TNYS20/500; 20/500a19.77; NARFM, TDOD, FRF, CA, RPCMCOD−1.3
QT761II:2/M6 months/6 monthsc.2952_2955delGCAGNRLONRLONA; NAFRF, RPCNALow‡
  • *The visual acuity was obtained when the patients were older than 4 years.

  • †Head circumference was measured in cm and corrected for age and sex following the discovery of the KIF11 mutations.

  • ‡No measurements was available, but the parents complained microcephaly in the patient.

  • AZ, avascular zone; CA, chorioretinal atrophy; CO, corneal opacity; FRF, falciform retinal fold; LP, light pursuit; MC, microcornea; MCOD, membrane connected with optic disc; NA, not available; NRLO, no response to light or object; NYS, nystagmus; OFC, occipitofrontal head circumference; RD, retinal detachment; RFM, retrolenticular fibrotic mass; RPC, retinal pigment change; TDOD, temporal dragging of optic disc.